Julien G. Colle

Marseille, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

ALDH1 inhibition by DIMATE maintains immune responses and promotes immunogenic remodeling in AML.

ALDH1 inhibition by DIMATE maintains immune responses and promotes immunogenic remodeling in AML.

Journal: Frontiers in immunology

Published: May 09, 2026

Impact of CDA Dynamics on Clinical Outcome of Patients With AML or High-Risk MDS Treated With Nucleoside Analogs.

Impact of CDA Dynamics on Clinical Outcome of Patients With AML or High-Risk MDS Treated With Nucleoside Analogs.

Journal: Hematological oncology

Published: December 23, 2024

Predicting the toxicity-efficacy ratio of venetoclax in real-world patients.

Predicting the toxicity-efficacy ratio of venetoclax in real-world patients.

Journal: Annals of hematology

Published: December 09, 2024

Body mass index affects imatinib exposure: Real-world evidence from TDM with adaptive dosing.

Body mass index affects imatinib exposure: Real-world evidence from TDM with adaptive dosing.

Journal: Fundamental & clinical pharmacology

Published: July 24, 2024

Reactive oxygen species and aldehyde dehydrogenase 1A as prognosis and theragnostic biomarker in acute myeloid leukaemia patients.

Reactive oxygen species and aldehyde dehydrogenase 1A as prognosis and theragnostic biomarker in acute myeloid leukaemia patients.

Journal: Journal of cellular and molecular medicine

Published: May 16, 2024

Therapy-related myeloid neoplasms after 177Lu-DOTATATE therapy for metastatic neuroendocrine neoplasia: CPX-351 consolidated by allogeneic stem cells transplantation as applicable therapeutic strategy.

Therapy-related myeloid neoplasms after 177Lu-DOTATATE therapy for metastatic neuroendocrine neoplasia: CPX-351 consolidated by allogeneic stem cells transplantation as applicable therapeutic strategy.

Journal: Leukemia & lymphoma

Published: April 12, 2023

Impact of Molecular Biology in Diagnosis, Prognosis, and Therapeutic Management of BCR::ABL1-Negative Myeloproliferative Neoplasm.

Impact of Molecular Biology in Diagnosis, Prognosis, and Therapeutic Management of BCR::ABL1-Negative Myeloproliferative Neoplasm.

Journal: Cells

Published: November 08, 2022

Clinical characteristics and outcomes of patients with haematologic malignancies and COVID-19 suggest that prolonged SARS-CoV-2 carriage is an important issue.

Clinical characteristics and outcomes of patients with haematologic malignancies and COVID-19 suggest that prolonged SARS-CoV-2 carriage is an important issue.

Journal: Annals of hematology

Published: July 05, 2021

The contribution of single-cell analysis of acute leukemia in the therapeutic strategy.

The contribution of single-cell analysis of acute leukemia in the therapeutic strategy.

Journal: Biomarker research

Published: December 04, 2020

Could daratumumab induce the maturation of plasmablasts in Plasmablastic lymphoma?-Potential therapeutic applications.

Could daratumumab induce the maturation of plasmablasts in Plasmablastic lymphoma?-Potential therapeutic applications.

Journal: European journal of haematology

Published: November 13, 2020

A rare case of pleural localisation of both metastatic Merkel cell carcinoma and chronic lymphocytic leukaemia.

A rare case of pleural localisation of both metastatic Merkel cell carcinoma and chronic lymphocytic leukaemia.

Journal: Cytopathology : official journal of the British Society for Clinical Cytology

Published: September 24, 2020

Different sensitivity of CD19-positive bone marrow and lymph node lymphoblasts may cause resistance to blinatumomab in relapsed B-cell acute lymphoblastic leukemia/lymphoma.

Different sensitivity of CD19-positive bone marrow and lymph node lymphoblasts may cause resistance to blinatumomab in relapsed B-cell acute lymphoblastic leukemia/lymphoma.

Journal: Leukemia & lymphoma

Published: January 05, 2020

Showing 1-12 of 22

Last Updated: 09/26/2026